Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (HK:3320)
HKEX:3320
Holding HK:3320?
Track your performance easily
3320 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$4.45 - HK$6.40
Previous CloseHK$4.96
Volume5.63M
Average Volume (3M)6.47M
Market Cap
HK$31.16B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)7.3
Beta0.65
Next Earnings
Oct 29, 2024EPS EstimateN/A
Last Dividend Ex-Date
Sep 10, 2024Dividend Yield3.42%
Share Statistics
EPS (TTM)0.66
Shares OutstandingN/A
10 Day Avg. Volume10,654,257
30 Day Avg. Volume6,472,747
Standard Deviation0.10
R-Squared0.19
Alpha0.00348
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.17
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$7.48Price Target Upside50.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
China Resources Pharmaceutical Group Ltd. News
PremiumCompany Announcements
China Resources Pharma Updates Board Structure
PremiumCompany Announcements
China Resources Pharma Reports Revenue Growth
PremiumCompany Announcements
China Resources Pharma Declares Mid-Year Dividend
PremiumCompany Announcements
China Resources Pharma Announces Leadership ReshufflePremiumCompany Announcements
CR Sanjiu Reports Strong Mid-Year Financial Growth
PremiumCompany Announcements
CR Boya Bio-pharmaceutical’s Mixed Mid-Year FinancialsPremiumCompany Announcements
KPC Reports Mixed Financials for Mid-2024
PremiumCompany Announcements
CR Double-Crane Reports Mixed Mid-Year FinancialsOptions Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
1.49% Mutual Funds
2.27% Other Institutional Investors
96.25% Public Companies and
Individual Investors
3320 FAQ
What was China Resources Pharmaceutical Group Ltd.’s price range in the past 12 months?
China Resources Pharmaceutical Group Ltd. lowest stock price was HK$4.45 and its highest was HK$6.40 in the past 12 months.
What is China Resources Pharmaceutical Group Ltd.’s market cap?
Currently, no data Available
When is China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date?
China Resources Pharmaceutical Group Ltd.’s upcoming earnings report date is Oct 29, 2024 which is in 38 days.
How were China Resources Pharmaceutical Group Ltd.’s earnings last quarter?
China Resources Pharmaceutical Group Ltd. released its earnings results on Aug 29, 2024. The company reported HK$0.451 earnings per share for the quarter, missing the consensus estimate of HK$0.472 by -HK$0.021.
Is China Resources Pharmaceutical Group Ltd. overvalued?
According to Wall Street analysts China Resources Pharmaceutical Group Ltd.’s price is currently Undervalued.
Does China Resources Pharmaceutical Group Ltd. pay dividends?
China Resources Pharmaceutical Group Ltd. pays a Annually dividend of HK$0.09 which represents an annual dividend yield of 3.42%. See more information on China Resources Pharmaceutical Group Ltd. dividends here
What is China Resources Pharmaceutical Group Ltd.’s EPS estimate?
China Resources Pharmaceutical Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Resources Pharmaceutical Group Ltd. have?
China Resources Pharmaceutical Group Ltd. has 6,282,510,300 shares outstanding.
What happened to China Resources Pharmaceutical Group Ltd.’s price movement after its last earnings report?
China Resources Pharmaceutical Group Ltd. reported an EPS of HK$0.451 in its last earnings report, missing expectations of HK$0.472. Following the earnings report the stock price went up 1.443%.
Which hedge fund is a major shareholder of China Resources Pharmaceutical Group Ltd.?
Currently, no hedge funds are holding shares in HK:3320
---
China Resources Pharmaceutical Group Ltd. Stock Smart Score
Company Description
China Resources Pharmaceutical Group Ltd.
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. The company's estimated operating income is approximately 56% distribution, 43% manufacturing, and less than 1% retail pharmacies.
---
3320 Stock 12 Month Forecast
Average Price Target
HK$7.48
▲(50.76% Upside)
Technical Analysis
Best Analysts Covering 3320
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
-0.33%
reiterated a buy rating 4 days ago
Copying Laurence Tam's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -0.33% per trade.
---